Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ORCHPHARMA Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Weak price momentum
Analysts have been downgrading forward EPS estimates
Low and declining ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ORCHPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ORCHPHARMA Bulk, Block & Insider Trades
ORCHPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Rights issue
Others
Bonus(1 new shares for 2 existing shares)BONUS ISSUE: One bonus share for every two shares held. Ex-date: 15th Sep 2005 Announced on: 20th Jul 2005
Rights issue(1 new shares @ 40 INR for 1 existing shares) Ex-date: 6th Jan 1995
Capital Reduction (CRD)Change in shares from 88964327 to 408164. Ex-date: 25th Jul 2019 Announced on: 17th Jul 2019
Company Profile
Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-infl... Read More
Key personnel
Shri. Ram Gopal AgarwalD
Non-Executive Non-Independent Chairman of the Board
Shri. Sunil Kumar Gupta
Chief Financial Officer
Mr. Kapil Dayya
Compliance Officer, Company Secretary
Dr. R. J. Sarangdhar
Vice President, Unit Head - API and FDF
Shri. Manish DhanukaD
Managing Director, Executive Director
Shri. Mridul DhanukaD
Whole Time Director
Dr. Srinivasan S
Head - CTD and IPM
Shri. Manoj Kumar GoyalD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Orchid Pharma Ltd.?
The current share price of Orchid Pharma Ltd. is ₹ 729.05 as of 09 Jan 2026.
What is the PE ratio of Orchid Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Orchid Pharma Ltd. is 67.67 as of the latest financial data.
What is the ROE and ROCE of Orchid Pharma Ltd.?
Orchid Pharma Ltd. has a Return on Equity (ROE) of 4.37% and a Return on Capital Employed (ROCE) of 2.17% as per the latest financial reports.
What is the market cap of Orchid Pharma Ltd.?
The market capitalization of Orchid Pharma Ltd. stands at ₹ 3,697.67 Cr.
What is the dividend yield of Orchid Pharma Ltd.?
The dividend yield of Orchid Pharma Ltd. is 0.00% based on the current market price.
What is the RSI of Orchid Pharma Ltd.?
The Relative Strength Index (RSI) of Orchid Pharma Ltd. is 32.11.
What is the FII and DII holding in Orchid Pharma Ltd.?
Foreign Institutional Investors (FII) hold 1.56% and Domestic Institutional Investors (DII) hold 18.24% of Orchid Pharma Ltd. shares.
What sector does Orchid Pharma Ltd. belong to?
Orchid Pharma Ltd. operates in the Healthcare sector.
What is the beta of Orchid Pharma Ltd. stock?
The beta of Orchid Pharma Ltd. stock is 1.16, indicating its volatility relative to the broader market.
